Monday, July 28

In the ongoing debate surrounding public health policies during the COVID-19 pandemic, Jay Bhattacharya has emerged as a controversial figure, particularly in relation to his advocacy for herd immunity and focused protection. Lambert Strether of Corrente argues that Bhattacharya’s elevation to a leadership position within the National Institutes of Health (NIH) is concerning given his...

Premium Membership Required

You must be a Premium member to access this content.

Join Now

Already a member? Log in here
Share.

Comments are closed.

Exit mobile version